Trials / Completed
CompletedNCT00111579
Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)
A Prospective, Randomized, Open-Label Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With Trivalent Inactivated Vaccine (TIV) in Children 6 to <36 Months of Age
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 52 (planned)
- Sponsor
- MedImmune LLC · Industry
- Sex
- All
- Age
- 6 Months – 36 Months
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to describe the level of serum antibody conferred by CAIV-T and TIV against homotypic and heterotypic influenza virus strains.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | CAIV-T | A total vol. of 0.2 mL will be administered intranasally (approx. 0.1 mL into each nostril)for ea. of two doses. |
| OTHER | TIV | A total vol. of 0.25 will be administered intramuscularly for each of two doeses. |
Timeline
- Start date
- 2005-05-01
- Primary completion
- 2006-01-01
- Completion
- 2006-01-01
- First posted
- 2005-05-24
- Last updated
- 2008-07-24
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00111579. Inclusion in this directory is not an endorsement.